Axel Ullrich

发表

Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors

A. Ullrich, B. Margolis, J. Schlessinger, 1992, Molecular and cellular biology.

HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor.

A. Ullrich, I. Lax, J. Schlessinger, 1989, The EMBO journal.

Novel signaling pathway suggested by SH3 domain-mediated p95vav/heterogeneous ribonucleoprotein K interaction.

O. Hobert, A. Ullrich, J. Schlessinger, 1994, The Journal of biological chemistry.

Separate endocytic pathways of kinase-defective and -active EGF receptor mutants expressed in same cells

A. Ullrich, J. Schlessinger, A. Honegger, 1990, The Journal of cell biology.

Differential signalling potential of insulin‐ and IGF‐1‐receptor cytoplasmic domains.

A. Ullrich, J. Schlessinger, R. Lammers, 1989, The EMBO journal.

SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange

J Ureña, A. Ullrich, M. White, 1993, Molecular and cellular biology.

Motogenic and morphogenic activity of epithelial receptor tyrosine kinases

M. Sachs, A. Obermeier, K. Weidner, 1996, The Journal of cell biology.

Phospholipase C‐gamma, a substrate for PDGF receptor kinase, is not phosphorylated on tyrosine during the mitogenic response to CSF‐1.

J. Downing, A. Ullrich, A. Zilberstein, 1989, The EMBO journal.

A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis

A. Ullrich, E. Van Obberghen, J. Schlessinger, 1987, Molecular and cellular biology.

High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domains.

A. Ullrich, B. Margolis, J. Schlessinger, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation.

I. Lax, J. Schlessinger, S. Felder, 1993, Biochemistry.

Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling

A. Ullrich, I. Lax, J. Schlessinger, 1988, Molecular and cellular biology.

Solution structure of the SH3 domain of phospholipase C-γ

J. Schlessinger, D. Kohda, V. Mandiyan, 1993, Cell.

Tyrosine phosphatase inhibition permits analysis of signal transduction complexes in p185HER2/neu-overexpressing human tumor cells.

A. Ullrich, J. Schlessinger, B. Jallal, 1992, The Journal of biological chemistry.

Identification of autophosphorylation sites of HER2/neu.

A. Zilberstein, B. Margolis, M. Dombalagian, 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Noncontiguous regions in the extracellular domain of EGF receptor define ligand-binding specificity.

A. Ullrich, I. Lax, J. Schlessinger, 1991, Cell regulation.

Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regions.

A. Ullrich, J. Schlessinger, A. Schmidt, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Transplantation of the human insulin gene into fertilized mouse eggs.

A. Ullrich, K. Bürki, Axel Ullrich, 1982, The EMBO journal.